Sidenafil pre-treatment promotes decompression sickness in rats.
Vascular bubble formation after decompression contributes to endothelial injuries which form the basis for the development of decompression sickness (DCS). Nitric oxide (NO) is a powerful vasodilator that contributes to vessel homeostasis. It has been shown that NO-releasing agent may reduce bubble...
Main Authors: | Jean-Eric Blatteau, Alf O Brubakk, Emmanuel Gempp, Olivier Castagna, Jean-Jacques Risso, Nicolas Vallée |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23580342/?tool=EBI |
Similar Items
-
Protective effects of fluoxetine on decompression sickness in mice.
by: Jean-Eric Blatteau, et al.
Published: (2012-01-01) -
Thirty-five Day Fluoxetine Treatment Limits Sensory-Motor Deficit and Biochemical Disorders in a Rat Model of Decompression Sickness
by: Caroline Cosnard, et al.
Published: (2017-09-01) -
Demonstration by Infra-Red Imaging of a Temperature Control Defect in a Decompression Sickness Model Testing Minocycline
by: Anne-Virginie Desruelle, et al.
Published: (2019-07-01) -
Tirofiban, a Glycoprotein IIb/IIIa Antagonist, Has a Protective Effect on Decompression Sickness in Rats: Is the Crosstalk Between Platelet and Leukocytes Essential?
by: Kate Lambrechts, et al.
Published: (2018-07-01) -
Evidence of a hormonal reshuffle in the cecal metabolome fingerprint of a strain of rats resistant to decompression sickness
by: Nicolas Vallee, et al.
Published: (2021-04-01)